Pharmaceutical and Biotechnology Market Size, Share, By Product (Biotechnology and Pharmaceutical), Age Group (Children & Adolescents, Adults, and Geriatric), Technology (Nanotechnology, Tissue Engineering & Regeneration, PCR & Sequencing, Artificial Intelligence (AI), Personalized Medicine, and Others), Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Disease Prevention, Cardiovascular Diseases, Neurological Diseases and Others), End User (Pharmaceutical Companies, Biotechnology Companies, Healthcare Providers, Research and Government Institutes, and Others), and Region - Trends, Analysis and Forecast till 2035

Pharmaceutical and biotechnology market size is accounted at USD 3.3 Trillion in 2025 and is expected to expand at USD 6.5 Trillion, by 2035 growing at a CAGR of 7.8%.

Pharmaceuticals are prescription medications, whereas biotechnology is the process of creating goods from living things through biological study.  The use of biotechnology to create medications is known as pharmaceutical biotechnology.  Pharmaceuticals are medications used for medical purposes, such cough syrup or sleeping pills, whereas biotechnology is the application of biological research methods to create goods and procedures generated from living things.  Improved healthcare, quicker medicine delivery, new and improved goods, better quality assurance, stronger patents, and greater FDA approval rates are some of the main benefits of pharmaceutical and biotechnology.

Factors driving the growth of the pharmaceutical and biotechnology market include the increasing prevalence of chronic diseases, the growing acceptance of biologics and biosimilars, the increased investment by governments worldwide in R&D to address unmet medical needs and promote innovation, the expansion of product portfolios by companies, the emergence of R&D hubs, the growing demand for synthetic biology, and the growing emphasis on advanced therapies.  The use of artificial intelligence (AI) and machine learning in drug discovery and development is also speeding up the process and increasing efficiency, which further contributes to the expansion of the target market. Other technological advancements in fields such as genomics, proteomics, and bioinformatics are also speeding up drug discovery and development. Personalized medicine, on the other hand, customizes treatments for each patient based on its genetic composition.